|
1
|
Malzkorn B and Reifenberger G: Practical
implications of integrated glioma classification according to the
World Health Organization classification of tumors of the central
nervous system 2016. Curr Opin Oncol. 28:494–501. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Winter SF, Loebel F and Dietrich J: Role
of ketogenic metabolic therapy in malignant glioma: A systematic
review. Crit Rev Oncol Hematol. 112:41–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrom QT, Gittleman H, Liao P, Rouse C,
Chen Y, Dowling J, Wolinsky Y, Kruchko C and Barnholtz-Sloan J:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2007–2011. Neuro Oncol. 16
Suppl 4:iv1–iv63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tanaka S, Louis DN, Curry WT, Batchelor TT
and Dietrich J: Diagnostic and therapeutic avenues for
glioblastoma: No longer a dead end? Nat Rev Clin Oncol. 10:14–26.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carlsson SK, Brothers SP and Wahlestedt C:
Emerging treatment strategies for glioblastoma multiforme. EMBO Mol
Med. 6:1359–1370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang J, Wang WF, Xie S, Zhang XL, Qi WF,
Zhou XP, Hu JX, Shi Q and Yu RT: Expression of β-transducin
repeat-containing E3 ubiquitin protein ligase in human glioma and
its correlation with prognosis. Oncol Lett. 9:2651–2656. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Y, Wang F, Liu Y, Yao Y, Lv X, Dong B,
Li J, Ren S, Yao Y and Xu Y: RNF135, RING finger protein, promotes
the proliferation of human glioblastoma cells in vivo and in vitro
via the ERK pathway. Sci Rep. 6:206422016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu L, Lu Y, Han D, Yao R, Wang H, Zhong S,
Luo Y, Han R, Li K, Fu J, et al: Rnf138 deficiency promotes
apoptosis of spermatogonia in juvenile male mice. Cell Death Dis.
8:e27952017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou YX, Chen SS, Wu TF, Ding DD, Chen XH,
Chen JM, Su ZP, Li B, Chen GL, Xie XS, et al: A novel gene RNF138
expressed in human gliomas and its function in the glioma cell line
U251. Anal Cell Pathol (Amst). 35:167–178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han MZ, Huang B, Chen AJ, Zhang X, Xu R,
Wang J and Li XG: High expression of RAB43 predicts poor prognosis
and is associated with epithelial-mesenchymal transition in
gliomas. Oncol Rep. 37:903–912. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang L, Zhang W, Li Y, Alvarez A, Li Z,
Wang Y, Song L, Lv D, Nakano I, Hu B, et al: SHP-2-upregulated ZEB1
is important for PDGFRalpha-driven glioma epithelial-mesenchymal
transition and invasion in mice and humans. Oncogene. 35:5641–5652.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bustin SA, Benes V, Garson JA, Hellemans
J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL,
et al: The MIQE guidelines: Minimum information for publication of
quantitative real-time PCR experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Zhang G, Wang Y, Elgehama A, Sun Y,
Li L, Gu Y, Guo W and Xu Q: Loss of periplakin expression is
associated with the tumorigenesis of colorectal carcinoma. Biomed
Pharmacother. 87:366–374. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Hu Y, Liu C, Wang Q, Han X, Han Y,
Xie XS, Chen XH, Li X, Siegel ER, et al: Human fibulin-3 protein
variant expresses anti-cancer effects in the malignant glioma
extracellular compartment in intracranial xenograft models.
Oncotarget. 8:106311–106323. 2017.PubMed/NCBI
|
|
20
|
Clingerman KJ and Summers L: Validation of
a body condition scoring system in rhesus macaques (Macaca
mulatta): inter- and intrarater variability. J Am Assoc Lab Anim
Sci. 51:31–36. 2012.PubMed/NCBI
|
|
21
|
Deng J, Wang L, Chen H, Hao J, Ni J, Chang
L, Duan W, Graham P and Li Y: Targeting epithelial-mesenchymal
transition and cancer stem cells for chemoresistant ovarian cancer.
Oncotarget. 7:55771–55788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Buonato JM and Lazzara MJ: ERK1/2 blockade
prevents epithelial-mesenchymal transition in lung cancer cells and
promotes their sensitivity to EGFR inhibition. Cancer Res.
74:309–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding C, Tang W, Fan X, Wang X, Wu H, Xu H,
Xu W, Gao W and Wu G: Overexpression of PEAK1 contributes to
epithelial-mesenchymal transition and tumor metastasis in lung
cancer through modulating ERK1/2 and JAK2 signaling. Cell Death
Dis. 9:8022018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brown JS and Jackson SP: Ubiquitylation,
neddylation and the DNA damage response. Open Biol. 5:1500182015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han D, Liang J, Lu Y, Xu L, Miao S, Lu LY,
Song W and Wang L: Ubiquitylation of Rad51d mediated by E3 ligase
Rnf138 promotes the homologous recombination repair pathway. PLoS
One. 11:e01554762016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang B, Qin J, Nie Y, Li Y and Chen Q:
Brain-derived neurotrophic factor propeptide inhibits proliferation
and induces apoptosis in C6 glioma cells. Neuroreport. 28:726–730.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang XQ, Bai HM, Li ST, Sun H, Min LZ, Tao
BB, Zhong J and Li B: Knockdown of HDAC1 expression suppresses
invasion and induces apoptosis in glioma cells. Oncotarget.
8:48027–48040. 2017.PubMed/NCBI
|
|
28
|
Hou M, Cheng Z, Shen H, He S, Li Y, Pan Y,
Feng C, Chen X, Zhang Y, Lin M, et al: High expression of CTHRC1
promotes EMT of epithelial ovarian cancer (EOC) and is associated
with poor prognosis. Oncotarget. 6:35813–35829. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jayachandran A, Dhungel B and Steel JC:
Epithelial-to-me-senchymal plasticity of cancer stem cells:
Therapeutic targets in hepatocellular carcinoma. J Hematol Oncol.
9:742016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Krebs AM, Mitschke J, Losada Lasierra M,
Schmalhofer O, Boerries M, Busch H, Boettcher M, Mougiakakos D,
Reichardt W, Bronsert P, et al: The EMT-activator Zeb1 is a key
factor for cell plasticity and promotes metastasis in pancreatic
cancer. Nat Cell Biol. 19:518–529. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pietilä M, Ivaska J and Mani SA: Whom to
blame for metastasis, the epithelial-mesenchymal transition or the
tumor microenvironment? Cancer Lett. 380:359–368. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-me-senchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zeng Z, Leng T, Feng X, Sun H, Inoue K,
Zhu L and Xiong ZG: Silencing TRPM7 in mouse cortical astrocytes
impairs cell proliferation and migration via ERK and JNK signaling
pathways. PLoS One. 10:e01199122015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Heigener DF, Gandara DR and Reck M:
Targeting of MEK in lung cancer therapeutics. Lancet Respir Med.
3:319–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Z, Dai H, Jia G, Li Y, Liu X and Ren
W: Insufficient radiofrequency ablation promotes human hepatoma
SMMC7721 cell proliferation by stimulating vascular endothelial
growth factor overexpression. Oncol Lett. 9:1893–1896. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dong F, Tian H, Yan S, Li L, Dong X, Wang
F, Li J, Li C, Cao Z, Liu X and Liu J: Dihydroartemisinin inhibits
endothelial cell proliferation through the suppression of the ERK
signaling pathway. Int J Mol Med. 35:1381–1387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang D, Lu C and Ai H: Rab5a is
overexpressed in oral cancer and promotes invasion through ERK/MMP
signaling. Mol Med Rep. 16:4569–4576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Morishita Y, Ookawara S, Hirahara I, Muto
S and Nagata D: HIF-1α mediates Hypoxia-induced
epithelial-mesenchymal transition in peritoneal mesothelial cells.
Ren Fail. 38:282–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mori H, Yao Y, Learman BS, Kurozumi K,
Ishida J, Ramakrishnan SK, Overmyer KA, Xue X, Cawthorn WP, Reid
MA, et al: Induction of WNT11 by hypoxia and hypoxia-inducible
factor-1α regulates cell proliferation, migration and invasion. Sci
Rep. 6:215202016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Park SY, Jang WJ, Yi EY, Jang JY, Jung Y,
Jeong JW and Kim YJ: Melatonin suppresses tumor angiogenesis by
inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res.
48:178–184. 2010. View Article : Google Scholar : PubMed/NCBI
|
